Literature DB >> 29651176

Cloning of ompA gene from Acinetobacter baumannii into the eukaryotic expression vector pBudCE4.1 as DNA vaccine.

Hossein Ansari1,2, Abbas Doosti3, Mohammad Kargar4, Mahdi Bijanzadeh5, Mojtaba Jaafarinia2.   

Abstract

Antibiotic resistant features of Acinetobacter baumannii is partly due to the decreased outer membrane proteins (OMPs) permeability. The OmpA is one of the most conserved proteins among A. baumannii with a considerable antigenic potential to stimulate the multidimensional immune system responses. The present study was aimed to clone the ompA gene into the eukaryotic expression vector with potential as DNA vaccine. The ompA gene of A. baumannii was amplified using polymerase chain reaction (PCR). The target DNA was cloned and sub-cloned into the pTZ57R/T and pBudCE4.1 vectors, respectively. The recombinant vectors containing ompA were then validated using colony PCR, vector sequencing and double-digestion strategies. The pBudCE4.1-ompA recombinant plasmid was transfected into the human dermal fibroblast cells (HDF) and presence of ompA transcript and protein was evaluated using reverse transcribed-PCR (RT-PCR) and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Our finding from colony PCR, sequencing and enzyme double digestion result confirmed that target gene has been successfully inserted into the pTZ57RT and pBudCE4.1. The presence of an expected band (1112 bp) in RT-PCR as wells as a ~ 38 kDa band during SDS-PAGE showed that the recombinant pBudCE4.1-ompA construct was efficiently transfected into the HDF cells and expressed. Altogether, our observation demonstrated that the recombinant pBudCE4.1-ompA construct was successfully produced although further experiments are needed.

Entities:  

Keywords:  Acinetobacter baumannii; DNA vaccine; Outer membrane protein; ompA gene

Year:  2018        PMID: 29651176      PMCID: PMC5891471          DOI: 10.1007/s12088-017-0705-x

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  26 in total

1.  Preparation and Transformation of Competent E. coli Using Calcium Chloride.

Authors:  Joseph Sambrook; David W Russell
Journal:  CSH Protoc       Date:  2006-06-01

2.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.

Authors:  Farzad Badmasti; Soheila Ajdary; Saeid Bouzari; Abbas Ali Imani Fooladi; Fereshteh Shahcheraghi; Seyed Davar Siadat
Journal:  Mol Immunol       Date:  2015-08-12       Impact factor: 4.407

Review 4.  Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

Authors:  George H Talbot; John Bradley; John E Edwards; David Gilbert; Michael Scheld; John G Bartlett
Journal:  Clin Infect Dis       Date:  2005-01-25       Impact factor: 9.079

5.  Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.

Authors:  Michael J McConnell; Carlos Rumbo; Germán Bou; Jerónimo Pachón
Journal:  Vaccine       Date:  2011-06-14       Impact factor: 3.641

6.  Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.

Authors:  Leticia V Bentancor; Abhisek Routray; Cagla Bozkurt-Guzel; Ana Camacho-Peiro; Gerald B Pier; Tomás Maira-Litrán
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

7.  The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Andrew D Cox; Frank St Michael; Evgeny V Vinogradov; Brad Spellberg; Nicole R Luke-Marshall; Anthony A Campagnari
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

8.  Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins.

Authors:  Sang Woo Kim; Chul Hee Choi; Dong Chan Moon; Jong Sook Jin; Jung Hwa Lee; Ji-Hyun Shin; Jung Min Kim; Yoo Chul Lee; Sung Yong Seol; Dong Taek Cho; Je Chul Lee
Journal:  FEMS Microbiol Lett       Date:  2009-10-13       Impact factor: 2.742

9.  Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii.

Authors:  Lauren B King; Edwin Swiatlo; Andrea Swiatlo; Larry S McDaniel
Journal:  FEMS Immunol Med Microbiol       Date:  2009-02-11

Review 10.  Molecular mechanisms for enhanced DNA vaccine immunogenicity.

Authors:  Lei Li; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2015-12-28       Impact factor: 5.217

View more
  6 in total

1.  Identification of Antigenic Properties of Acinetobacter baumannii Proteins as Novel Putative Vaccine Candidates Using Reverse Vaccinology Approach.

Authors:  Tohid Piri-Gharaghie; Abbas Doosti; Seyed Abbas Mirzaei
Journal:  Appl Biochem Biotechnol       Date:  2022-06-07       Impact factor: 3.094

2.  Study of the immunogenicity of outer membrane protein A (ompA) gene from Acinetobacter baumannii as DNA vaccine candidate in vivo.

Authors:  Hossein Ansari; Maryam Tahmasebi-Birgani; Mahdi Bijanzadeh; Abbas Doosti; Mohammad Kargar
Journal:  Iran J Basic Med Sci       Date:  2019-06       Impact factor: 2.699

3.  Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.

Authors:  Mohammad Chehelgerdi; Abbas Doosti
Journal:  J Nanobiotechnology       Date:  2020-04-21       Impact factor: 10.435

4.  Cloning, expression, purification and functional analysis of a specific multi-epitope protein from multi drug resistance Acinetobacter baumannii.

Authors:  Zahra Davoudi; Amirhossein Taromchi; Bahram Kazemi; Mojgan Bandehpour; Nariman Mosaffa
Journal:  Iran J Microbiol       Date:  2021-10

Review 5.  Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years.

Authors:  Yong Chiang Tan; Chandrajit Lahiri
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 6.  Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection.

Authors:  Dan Nie; Yue Hu; Zhou Chen; Mingkai Li; Zheng Hou; Xiaoxing Luo; Xinggang Mao; Xiaoyan Xue
Journal:  J Biomed Sci       Date:  2020-01-18       Impact factor: 8.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.